Citius Oncology, Inc. CTOR Cash Flow Statement
| FY'25 | FY'24 | ||
|---|---|---|---|
| -$24.76M-17.1% | -$21.15M-66.6% | ||
| $8.32M+11.0% | $7.5M+282% | ||
| $1.06M+83.5% | $576K0.0% | ||
| —— | —— | ||
| $12.65M+493% | $2.13M— | ||
| $9.52M+293% | $2.42M+102% | ||
| —— | -$86.81K+21.2% | ||
| —— | —— | ||
| -$5.49M-1,088% | $555.64K— | ||
| $5.75M+15.0% | $5M— | ||
| $6.42M— | —— | ||
| -$5.75M+24.0% | -$7.57M+88.8% | ||
| —— | $2.36M— | ||
| —— | —— | ||
| —— | —— | ||
| $15.17M+115% | $7.05M— | ||
| $3.92M— | —— | ||
| $187.39K— | —— | ||
| —— | —— | ||
| $9.52M+293% | $2.42M+102% | ||
| $8.92M— | —— | ||
| —— | —— | ||
| —— | —— | ||
| —— | —— | ||
| $5.75M+15.0% | $5M— | ||
| —— | —— | ||
| —— | $37.01M— | ||
| —— | —— | ||
| -$0.34-9.7% | -$0.31-63.2% | ||
| —— | —— | ||
| —— | —— | ||
| $8.78M+7.8% | $8.15M+37.8% | ||
| —— | —— | ||
| -$23.7M-15.2% | -$20.57M-69.7% | ||
| $218.03K— | —— | ||
| —— | —— | ||
| $36.37K— | —— | ||
| -$181.66K— | —— | ||
| $116.61K-2.1% | $119.14K-1.9% | ||
| $1.92M-2.2% | $1.96M+31.2% | ||
| —— | $2.75M— | ||
| —— | —— | ||
| —— | —— | ||
| —— | —— | ||
| —— | —— | ||
| —— | —— | ||
| —— | $33.18M— | ||
| —— | $28.4M— | ||
| $1.37M-77.7% | $6.13M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Citius Oncology, Inc. generate?
- Citius Oncology, Inc. (CTOR) generated -$13.9M in operating cash flow over the trailing twelve months.
- Where does Citius Oncology, Inc.'s cash flow data come from?
- Every line is extracted from Citius Oncology, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.